| Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1α, vascular endothelial growth factor A, and induction of thrombospondin-1 … T Neill, H Painter, S Buraschi, RT Owens, MP Lisanti, L Schaefer, ... Journal of Biological Chemistry 287 (8), 5492-5506, 2012 | 184 | 2012 |
| Human cytomegalovirus epidemiology and relationship to tuberculosis and cardiovascular disease risk factors in a rural Ugandan cohort L Stockdale, S Nash, A Nalwoga, H Painter, G Asiki, H Fletcher, R Newton PloS one 13 (2), e0192086, 2018 | 53 | 2018 |
| RUTI Vaccination Enhances Inhibition of Mycobacterial Growth ex vivo and Induces a Shift of Monocyte Phenotype in Mice SA Prabowo, H Painter, A Zelmer, SG Smith, K Seifert, M Amat, ... Frontiers in immunology 10, 894, 2019 | 33 | 2019 |
| Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells H Painter, SA Prabowo, F Cia, L Stockdale, R Tanner, S Willcocks, ... Scientific Reports 10 (1), 3311, 2020 | 12 | 2020 |
| HIV, HCMV and mycobacterial antibody levels: a cross‐sectional study in a rural Ugandan cohort L Stockdale, S Nash, A Nalwoga, L Gibson, H Painter, J Raynes, G Asiki, ... Tropical Medicine & International Health 24 (2), 247-257, 2019 | 11 | 2019 |
| Host transcriptomic signatures of tuberculosis can predict immune reconstitution inflammatory syndrome in HIV patients SK Mbandi, H Painter, A Penn‐Nicholson, A Toefy, M Erasmus, ... European journal of immunology 52 (7), 1112-1119, 2022 | 7 | 2022 |
| How can we improve priority-setting for investments in health research? A case study of tuberculosis MS Khan, A Rahman-Shepherd, H Painter, H Fletcher Health research policy and systems 17, 1-9, 2019 | 4 | 2019 |
| Development and application of the direct mycobacterial growth inhibition assay: a systematic review H Painter, E Harriss, HA Fletcher, H McShane, R Tanner Frontiers in Immunology 15, 1355983, 2024 | 1 | 2024 |
| Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA) R Tanner, A Zelmer, H Painter, E Stylianou, N Pinpathomrat, ... bioRxiv, 2021.02. 14.431105, 2021 | 1 | 2021 |
| Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple … H Painter, S Willcocks, A Zelmer, R Reljic, R Tanner, H Fletcher Tuberculosis 146, 102494, 2024 | | 2024 |
| Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependent H Painter, SE Larsen, BD Williams, HFM Abdelaal, SL Baldwin, ... bioRxiv, 2024.06. 21.600067, 2024 | | 2024 |
| Accelerating the preclinical development of effective vaccines for protection against Mycobacterium tuberculosis HE Painter London School of Hygiene & Tropical Medicine, 2021 | | 2021 |
